Lv1
50 积分 2024-11-27 加入
Factors contributing to the nonlinear pharmacokinetics of astegolimab: a close examination of potential causes
22小时前
已完结
Targeting alarmins in asthma- From the bench to the clinic
22小时前
已完结
Gel filtration chromatography as a method for removing bacterial endotoxin from antibody preparations
10天前
已完结
Omalizumab: a monoclonal anti-IgE antibody
15天前
已关闭
Depemokimab, the first ultra-long-acting anti-IL-5 monoclonal antibody for severe eosinophilic asthma
15天前
已完结
Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody
24天前
已完结
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
26天前
已完结
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
26天前
已完结
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Stapokibart in Healthy Volunteers and Adult Subjects with Atopic Dermatitis
29天前
已完结
Stapokibart: First Approval
29天前
已完结
皖公网安备34019202002308
